ArticleThe oncologist2019

First-in-Human Phase I Study of Merestinib, an Oral Multikinase Inhibitor, in Patients with Advanced Cancer.

Aiwu Ruth He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.